Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Improving Drug Treatment by Understanding Genetic

Media release
Tuesday 27 June, 2006.

Improving Drug Treatment by Understanding Genetic Make-Up

Researchers from around the country are converging on Christchurch ( Wed. June 28) for a scientific symposium on pharmacogenomics, an emerging area of innovative health research that seeks to understand how differences in genetic makeup can affect an individual's response to drugs.

The symposium is organised by the Carney Centre for Pharmacogenomics, a University of Otago research centre based at the Christchurch School of Medicine and Health Sciences. The Director, Associate Professor Martin Kennedy, has convened the meeting to mark the first anniversary of the opening.

By applying modern genetic methods and knowledge derived from the human genome project, this research is aimed at clarifying how certain drugs work, and how they can be more effectively used.

Speakers will address topics including the treatment of inflammatory bowel disease (IBD), asthma, and mental disorders such as depression.

Associate Professor Murray Barclay and Dr Rebecca Roberts, (Christchurch School of Medicine & Health Sciences), will describe their findings on genes which influence treatment of inflammatory bowel disease.

The drugs used to treat this serious illness are very good when they work, but they only work in a proportion of patients, and can make some people quite ill.

Associate Professor Barclay says "It's now very clear that some of these problems with certain drugs are due to the genetic makeup of each patient. Some will have a genetic profile that means the treatment will be safe and effective, and others will not respond, and may suffer side-effects."

"It's our goal to better define these important genetic differences, and use these to improve our treatment of IBD."

The application of genetic analysis to better understand adverse drug reactions identified by the New Zealand Pharmacovigilance Centre (University of Otago, Dunedin) will be discussed by Dr David Clark. Its extensive monitoring of drugs to identify new adverse reactions, the Intensive Medicines Monitoring Programme, is amongst the best in the world. It offers great potential for better understanding the role that genetic differences play in the adverse effects of drugs.

Modern technologies for genetic analyses will also be widely discussed. Dr Andrew Fellowes (Canterbury Health Laboratories) will describe results from a new DNA chip-based system for identifying genes that affect drug metabolism. This machine, the only one of its kind in NZ and Australia, is the first to be approved by the US Food and Drug Administration for use in clinical pharmacogenomics.

"There’s tremendous international interest in pharmacogenomics, and I intend this to be an annual meeting that will allow us to gauge our progress and explore the value of new research results in this area" says Associate Professor Kennedy.

"Although much of this work is some way from being clinically useful, wherever we see an opportunity to apply the research to improve treatment we certainly plan to do that. One of the main goals of the Carney Centre is to ensure that pharmacogenomic knowledge, whether from our own research or from overseas, is applied in a timely and appropriate fashion to benefit New Zealanders."

The Symposium will take place at the Millennium Hotel, Cathedral Square on Wednesday June 28 from 9am.

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>

ALSO:

Half A Billion Accounts: Yahoo Confirms Huge Data Breach

The account information may have included names, email addresses, telephone numbers, dates of birth, hashed passwords (the vast majority with bcrypt) and, in some cases, encrypted or unencrypted security questions and answers. More>>

Rural Branches: Westpac To Close 19 Branches, ANZ Looks At 7

Westpac confirms it will close nineteen branches across the country; ANZ closes its Ngaruawahia branch and is consulting on plans to close six more branches; The bank workers union says many of its members are nervous about their futures and asking ... More>>

Interest Rates: RBNZ's Wheeler Keeps OCR At 2%

Reserve Bank governor Graeme Wheeler kept the official cash rate at 2 percent and said more easing will be needed to get inflation back within the target band. More>>

ALSO:

Half Full: Fonterra Raises Forecast Payout As Global Supply Shrinks

Fonterra Cooperative Group, the dairy processor which will announce annual earnings tomorrow, hiked its forecast payout to farmers by 50 cents per kilogram of milk solids as global supply continues to decline, helping prop up dairy prices. More>>

ALSO:

Results:

Meat Trade: Silver Fern Farms Gets Green Light For Shanghai Maling Deal

The government has given the green light for China's Shanghai Maling Aquarius to acquire half of Silver Fern Farms, New Zealand's biggest meat company, with ministers satisfied it will deliver "substantial and identifiable benefit". More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news